Cleared Traditional

TDX DIGITOXIN (K842280) - FDA 510(k) Clearance

Class II Toxicology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K842280 · Abbott Laboratories · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1984
Decision
69d
Days
Class 2
Risk

K842280 is an FDA 510(k) clearance for the TDX DIGITOXIN. Classified as Enzyme Immunoassay, Digitoxin (product code LFM), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on August 16, 1984 after a review of 69 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3300 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

Submission Details

510(k) Number K842280 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 08, 1984
Decision Date August 16, 1984
Days to Decision 69 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d faster than avg
Panel avg: 87d · This submission: 69d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LFM Enzyme Immunoassay, Digitoxin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - LFM Enzyme Immunoassay, Digitoxin

All 14
Devices cleared under the same product code (LFM) and FDA review panel - the closest regulatory comparables to K842280.
MILENIA (TM) DIGITOXIN
K900013 · Diagnostic Products Corp. · Mar 1990
ACA(R) DIGITOXIN (DGTX) METHOD
K891094 · E.I. Dupont DE Nemours & Co., Inc. · Apr 1989
STRATUS DIGITOXIN FLUOROMETRIC ENZYME IMMUNOASSAY
K862067 · American Dade · Jun 1986
SOPHEIA/MP DIGITOXIN EIA KIT
K842578 · Diagnostic Products Corp. · Aug 1984
SOPHEIA DIGITOXIN EIA KIT & COMPONENTS
K830035 · Diagnostic Products Corp. · Jan 1983